
- May 2008
- Volume 25
- Issue 5
The link between lifestyle factors and hypertension in adolescents
Dasgupta has demonstrated that adolescent Canadian boys experience an increased risk of hypertension during longitudinal follow-up compared with girls.
Dasgupta
Dasgupta's study reinforces the known association between lifestyle factors, such as diet, exercise, and hypertension, and demonstrates these associations in adolescents. There is an alarming epidemic of obesity in the United States among adults and children. Unfortunately, modern society has fostered behaviors that are detrimental to cardiovascular health, including physical inactivity and poor diet. Children are spending more time watching television and playing computer and video games, and less time being physically active. Their diets include high-calorie sugary drinks and fat-laden fast food.
Dasgupta's study and others have led to public health initiatives to improve society's high-risk behaviors. One example is some regions of the country banning the use of trans fats, which are known to increase the risk of cardiovascular disease. It is imperative that the trends in obesity and physical inactivity be controlled and reversed, especially in children, because they are resulting in an epidemic of metabolic syndrome and diabetes. We should be advocating the Dietary Approaches to Stop Hypertension (DASH) diet, which has been demonstrated to lower blood pressure.3 This diet has been incorporated into the latest American Heart Association recommendations and is high in fruits, vegetables, whole grains, and calcium, but low in saturated fats. The study by Dasgupta demonstrates that particular attention must be focused on adolescent boys, who apparently develop hypertension at a faster rate than girls during the adolescent years.
Articles in this issue
almost 18 years ago
One size doesn't fit all in medicinealmost 18 years ago
Cholesterol fractions and heart disease mortality in older menalmost 18 years ago
The importance of preventive cardiologyalmost 18 years ago
Prasugrel: An antiplatelet on the horizon


























































